HEME Home Transfusion Program

Clinical trial NCT06487247 · RECRUITING

Trial details

NCT number: NCT06487247
Sponsor: Dana-Farber Cancer Institute
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Leukemia Myeloma Myelodysplastic Syndromes Hematologic Malignancy Hematologic Diseases Lymphoma

Start date: 2025-09-10
Primary completion: 2029-05-31
Enrollment: 700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.